Anavex Life Sciences Corp (AVXL)

[abew4me]

Yes. Based on the FDA's 6 to 3 vote against ACAD's drug to treat Rett, it's important that Anavex demonstrates a very strong and convincing safety record...to go along with the efficacy data.

Remember, ACAD's drug was shown to be effective in treating Rett...but the side effects (i.e. safety record) was too detrimental for the FDA to approve it. IMO

I think it was very astute for Anavex to wait for the completion of the 48-week PDD OLE so they can include that safety data with the AVATAR P3 results.